Comparison of plasma markers by associated co-morbidity in 331 patients with atrial fibrillation and HF
| (a) vWf (IU/dl) with and without co-morbidity | |||
|---|---|---|---|
| Co-morbid factors | Co-morbidity | p Value | |
| Present | Absent | ||
| Men | 153 (29) | 155 (31) | 0.7 |
| Age >75 years | 157 (26) | 153 (31) | 0.2 |
| Ever smoked | 154 (27) | 153 (33) | 0.7 |
| Prior cerebral ischaemia | 155 (27) | 154 (30) | 0.8 |
| Hypertension | 155 (29) | 152 (30) | 0.3 |
| Diabetes mellitus | 162 (30) | 152 (29) | 0.007 |
| Peripheral vascular disease | 161 (25) | 153 (30) | 0.09 |
| Prior MI | 154 (26) | 154 (31) | 0.9 |
| Mitral regurgitation | 153 (29) | 156 (31) | 0.6 |
| (b) sP-sel (ng/ml) with and without co-morbidity | |||
|---|---|---|---|
| Co-morbid factors | Co-morbidity | p Value | |
| Present | Absent | ||
| vWf is expressed as mean (1 SD) and compared by two-sample t test. sP-sel is expressed as median (interquartile range) and compared by Mann Whitney U test. | |||
| Men | 33 (26–41) | 30 (23–39) | 0.1 |
| Age >75 years | 31 (25–39) | 33 (26–40) | 0.2 |
| Ever smoked | 33 (26–42) | 30 (23–39) | 0.03 |
| Prior cerebral ischaemia | 31 (23–38) | 33 (26–41) | 0.05 |
| Hypertension | 32 (25–40) | 34 (26–41) | 0.3 |
| Diabetes mellitus | 34 (28–42) | 31 (25–40) | 0.06 |
| Peripheral vascular disease | 37 (29–45) | 32 (25–39) | 0.03 |
| Prior MI | 34 (28–44) | 32 (25–39) | 0.03 |
| Mitral regurgitation | 32 (25–41) | 31 (26–39) | 0.8 |